L773:1472 9792 OR L773:1873 281X
Sökning: L773:1472 9792 OR L773:1873 281X > (2020-2024) > A high content scre...
A high content screening assay for discovery of antimycobacterial compounds based on primary human macrophages infected with virulent Mycobacterium tuberculosis
-
- Kalsum, Sadaf (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten,Karolinska Inst, Sweden
-
- Otrocka, Magdalena (författare)
- Karolinska Inst, Sweden; Polish Acad Sci, Poland
-
- Andersson, Blanka (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
- visa fler...
- visa färre...
- (creator_code:org_t)
- CHURCHILL LIVINGSTONE, 2022
- 2022
- Engelska.
- Ingår i: Tuberculosis. - : CHURCHILL LIVINGSTONE. - 1472-9792 .- 1873-281X. ; 135
- Tidskriftsartikel (refereegranskat)
Abstract
Ämnesord
Stäng
- Drug resistance in Mycobacterium tuberculosis is an emerging threat that makes the discovery of new candidate drugs a priority. In particular, drugs with high sterilizing activity within host cells are needed to improve efficacy and reduce treatment duration. We aimed to develope and validate a High Content Screening assay based on Mycobacterium tuberculosis-infected primary human monocyte-derived macrophages as its natural reservoir. Infected primary human monocyte-derived macrophages were exposed to control antibiotics or tested compounds on 384 well plates. Intracellular bacterial growth and macrophage numbers were evaluated using an ImageXpress High Content Screening system and Z-factor was calculated to assess the reproducibility. The combination of isoniazid and rifampicin as a positive control rendered a Z-factor above 0.4, demonstrating suitability of the assay for screening and compound profiling purposes. In a validation experiment, isoniazid, rifampicin, moxifloxacin and levofloxacin all effectively inhibited intracellular growth as expected. Finally, a pilot screening campaign including 5700 compounds from diverse libraries resulted in the identification of three compounds with confirmed antimycobacterial activity in the low micromolar range and low host cell toxicity. The assay represents an attractive screening platform for both academic research on host-pathogen mechanisms in tuberculosis and for the identification and characterization of novel antimycobacterial compounds.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
Nyckelord
- Mycobacterium tuberculosis; Primary human monocyte-derived macro-phages; Phenotypic assay; High content screening
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta mer i SwePub
- Av författaren/redakt...
- Kalsum, Sadaf
- Otrocka, Magdale ...
- Andersson, Blank ...
- Welin, Amanda
- Schön, Thomas
- Jenmalm-Jensen, ...
- visa fler...
- Lundback, Thomas
- Lerm, Maria
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Medicinska och f ...
- och Mikrobiologi ino ...
- Artiklar i publikationen
- Tuberculosis
- Av lärosätet
- Linköpings universitet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
